DOI:

Kartagener's Syndrome

Annick Weustink1,MD; Eleni C. Vourvouri1,2, MD, PhD; Michail I. Papafaklis2, MD; Georgios Sianos2*, MD, PhD

A 46-year-old man with Kartagener’s Syndrome (primary ciliary diskinesia, autosomal recessive disorder with dextrocardia, situs inversus, bronchiectasis and paranasal sinusitis) presented with new onset angina. Coronary arteriography revealed severe three-vessel disease with occluded left anterior descending and circumflex coronary arteries. Due to severe pulmonary disease, coronary artery bypass surgery was not considered as the first therapeutic option. He underwent successful percutaneous multivessel revascularisation with implantation of paclitaxel-eluting stents. Control coronary angiography nine months after the procedure revealed no signs of restenosis. The patient remains asymptomatic at two years.

Figure 1. Dual source 64 multi-slice computed tomography volume-rendered image of the heart and the thoracic cage demonstrating the dextrocardia.

AA: ascending aorta; DA: descending aorta; LAD: left anterior descending; LCx: left circumflex; PA: pulmonary artery; RCA: right coronary artery; RI: ramus intermedius; A: anterior; L: left; P: posterior; R: right

Figure 2. Dual source 64 multi-slice computed tomography volume-rendered image of the lungs depicting the extensive bronchiectasis.
MB: main bronchus; L: left; R: right

Figure 3. Left heart ventriculography (a) and post-procedural simultaneous left and right coronary arteriography (b) in left anterior oblique projection showing the long axis of the heart.

AA: ascending aorta; LAD: left anterior descending; LCx: left circumflex; LV: left ventricle; RCA: right coronary artery; RI: ramus intermedius; S: spine

Online data supplement

Video 1. Angiography coronaries

Video 2. Angiography left ventricle

Video 3. MSCT coronaries

Video 4. MSCT dextrocardia

Volume 3 Number 2
Aug 20, 2007
Volume 3 Number 2
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-25-00022 Sep 15, 2025
An ongoing quest to discern the optimal antithrombotic therapy after TAVI
Hayashida K and Iwata J
free

Translational research

10.4244/EIJ-D-24-01000 Sep 15, 2025
DurAVR – a novel biomimetic balloon-expandable transcatheter valve for TAVI, valve-in-valve TAVI and redo-TAVI
Meier D et al
open access

Research Correspondence

10.4244/EIJ-D-25-00255 Sep 15, 2025
Redo-TAVI with the ACURATE platform for failure of short-frame transcatheter heart valves
Tarantini G et al

Original Research

10.4244/EIJ-D-24-01066 Sep 15, 2025
VARC-HBR criteria validation in TAVI patients on oral anticoagulation
Overduin D et al

Editorial

10.4244/EIJ-E-25-00038 Sep 15, 2025
Evolving cutoff values for optimising left main stenting with intravascular imaging
de la Torre Hernandez J
free

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free

Flashlight

10.4244/EIJ-D-25-00121 Sep 15, 2025
Calcium mapping by 3DStent technology
Amabile N and Benamer H
Trending articles
56.1

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
56.1

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
50.15

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free
28.25

Clinical research

10.4244/EIJ-D-19-01006 Aug 7, 2020
Coronary collaterals and myocardial viability in patients with chronic total occlusions
Schumacher S et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved